germans trias i pujol - Fundació Institut d'Investigació en Ciències de ...

Fundació Institut d'Investigació
en Ciències de la Salut
Germans Trias i Pujol
The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV‐1
subtypes.
JAIDS‐J ACQ IMM DEF 2006 Mar;41(3):352‐60
IF: 3,946
Weber J, Weberova J, Carobene M, Mirza M, Martinez‐Picado J, Kazanjian P, Quinones‐Mateu ME.
Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent
proteins to examine the contribution of pol and env genes to overall HIV‐1 replicative fitness.
J VIROL METHODS 136(1‐2):102‐117.
IF: 2,097
Weber R, Sabin CA, Friis‐Moller N, Reiss P, El‐Sadr WM, Kirk O, Dabis F, Law MG, Pradier C, De Wit S, Akerlund B,
Calvo G, Monforte A, Rickenbach M, Ledergerber B, Phillips AN, Lundgren JD.
Liver‐related deaths in persons infected with the human immunodeficiency virus: the D:A:D study.
ARCH INTERN MED 2006 Aug 14‐28;166(15):1632‐41.
IF: 7,92
Yeni P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH,
Mijch A, Meiffredy V, Salzberger B. (INITIO Trial International Co‐ordinating Committee)
Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing
non‐nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open‐label randomised trial.
LANCET 2006 Jul 22;368(9532):287‐98.
IF: 25,8
Youle M, Staszweski S, Clotet B, Arribas JR, Blaxhult A, Carosi G, DeJesus E, Di Perri G, Estrada V, Fisher M, Kovacs
C, Kulasegaram R, Lazzarin A, Marriott D, Munoz L, Reynes J, Shalit P, Slim J, Tsoukas C, Vaccaro A, Vera J.
Concomitant use of an active boosted protease inhibitor with enfuvirtide in treatment‐experienced, HIV‐infected
individuals: Recent data and consensus recommendations.
HIV CLIN TRIALS 2006 Mar‐Apr;7(2):86‐96
IF: 1,704
Estudi de la resposta immunitària normal i patològica
Aloisi F, Pujol‐Borrell R.
Lymphoid neogenesis in chronic inflammatory diseases.
NAT REV IMMUNOL 2006; 6(3):205‐217.
IF: 28,697
Canton A, Trainer PJ, Martinez‐Caceres E, Simo R.
Effect of growth hormone in an experimental model of protein hypercatabolism induced by glucocorticoids.
HORM METAB RES 2006; 38(9):556‐562.
IF: 1,997
Faner R, Casamitjana N, Coll J, Caro P, Pujol‐Borrell R, Palou E, Juan M.
Real‐time PCR using fluorescent resonance emission transfer probes for HLA‐B typing.
HUM IMMUNOL 2006; 67(4‐5):374‐385.
IF: 2,605
Ferrer‐Francesch X, Caro P, Alcalde L, Armengol MP, Ashhab Y, Lucas‐Martin A, Martinez‐Caceres EM, Juan M,
Pujol‐Borrell R.
One‐tube‐PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different
Pàgina 58/177